These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 2066785)

  • 1. Indium-111-labeled B72.3 monoclonal antibody in the detection and staging of breast cancer: a phase I study.
    Lamki LM; Buzdar AU; Singletary SE; Rosenblum MG; Bhadkamkar V; Esparza L; Podoloff DA; Zukiwski A; Hortobagyi GN; Murray JL
    J Nucl Med; 1991 Jul; 32(7):1326-32. PubMed ID: 2066785
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunolymphoscintigraphy in breast cancer: evaluation using 131I-labeled monoclonal antibody B72.3.
    Fig LM; Brown RS; von Moll L; Appelman HD; Stevens R; Harness J; August D; Sondak VK; Chang AE; Zasadny KR; Fisher SJ; Johnson JW; Wicha MS; Colcher D; Lichter AS; Wahl RL
    Nucl Med Biol; 1998 Apr; 25(3):251-60. PubMed ID: 9620631
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lymphoscintigraphy of human colorectal carcinoma metastases in athymic mice by use of radioiodinated B72.3 monoclonal antibody.
    Shah SA; Gallagher BM; Sands H
    J Natl Cancer Inst; 1987 Jun; 78(6):1069-77. PubMed ID: 3473248
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Autoradiographic evaluation of radiolabeled monoclonal antibody B72.3 distribution in tumor and lymph nodes of adenocarcinoma patients.
    Roselli M; Hitchcock CL; Molinolo A; Milenic DE; Colcher D; Martin EW; Hinkle GH; Schlom J
    Anticancer Res; 1995; 15(3):975-84. PubMed ID: 7645989
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics of indium-111-labeled B72.3 monoclonal antibody in colorectal cancer patients.
    Webster WB; Harwood SJ; Carroll RG; Morrissey MA
    J Nucl Med; 1992 Apr; 33(4):498-504. PubMed ID: 1552331
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differences in biodistribution of indium-111-and iodine-131-labeled B72.3 monoclonal antibodies in patients with colorectal cancer.
    Yokoyama K; Carrasquillo JA; Chang AE; Colcher D; Roselli M; Sugarbaker P; Sindelar W; Reynolds JC; Perentesis P; Gansow OA
    J Nucl Med; 1989 Mar; 30(3):320-7. PubMed ID: 2738661
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phase I study of 90Y-labeled B72.3 intraperitoneal administration in patients with ovarian cancer: effect of dose and EDTA coadministration on pharmacokinetics and toxicity.
    Rosenblum MG; Verschraegen CF; Murray JL; Kudelka AP; Gano J; Cheung L; Kavanagh JJ
    Clin Cancer Res; 1999 May; 5(5):953-61. PubMed ID: 10353726
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical evaluation of indium-111-labeled chimeric anti-CEA monoclonal antibody.
    Wong JY; Thomas GE; Yamauchi D; Williams LE; Odom-Maryon TL; Liu A; Esteban JM; Neumaier M; Dresse S; Wu AM; Primus FJ; Shively JE; Raubitschek AA
    J Nucl Med; 1997 Dec; 38(12):1951-9. PubMed ID: 9430476
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Complementation of intracavitary and intravenous administration of a monoclonal antibody (B72.3) in patients with carcinoma.
    Colcher D; Esteban J; Carrasquillo JA; Sugarbaker P; Reynolds JC; Bryant G; Larson SM; Schlom J
    Cancer Res; 1987 Aug; 47(15):4218-24. PubMed ID: 3607761
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Breast tumor radioimmunodetection with a 111In-labeled monoclonal antibody (MA5) against a mucin-like antigen.
    Major PP; Dion AS; Williams CJ; Mattes MJ; Wang T; Rosenthall L
    Cancer Res; 1990 Feb; 50(3 Suppl):927s-931s. PubMed ID: 2297743
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human breast tumor imaging using 111In labeled monoclonal antibody: athymic mouse model.
    Khaw BA; Bailes JS; Schneider SL; Lancaster J; Powers J; Strauss HW; Lasher JC; McGuire WL
    Eur J Nucl Med; 1988; 14(7-8):362-6. PubMed ID: 3181185
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Breast cancer imaging with mouse monoclonal antibodies.
    Major P; Wang TQ; Ishida M; Unger M; Rosenthall L
    Eur J Nucl Med; 1989; 15(10):655-60. PubMed ID: 2806327
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of humoral immune responses against a macrocyclic chelating agent (DOTA) in cancer patients receiving radioimmunoconjugates for imaging and therapy.
    Kosmas C; Snook D; Gooden CS; Courtenay-Luck NS; McCall MJ; Meares CF; Epenetos AA
    Cancer Res; 1992 Feb; 52(4):904-11. PubMed ID: 1737353
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunolymphscintigraphy of axillary lymph node metastases in breast cancer patients using monoclonal antibodies: first clinical findings.
    Mandeville R; Pateisky N; Philipp K; Kubista E; Dumas F; Grouix B
    Anticancer Res; 1986; 6(6):1257-63. PubMed ID: 3813482
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Staging of carcinoma of the breast using a hand-held gamma detecting probe and monoclonal antibody B72.3.
    Nieroda CA; Mojzisik C; Sardi A; Farrar WB; Hinkle G; Siddiqi MA; Ferrara PJ; James A; Schlom J; Thurston MO
    Surg Gynecol Obstet; 1989 Jul; 169(1):35-40. PubMed ID: 2740968
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative biodistributions of yttrium- and indium-labeled monoclonal antibody B72.3 in athymic mice bearing human colon carcinoma xenografts.
    Roselli M; Schlom J; Gansow OA; Raubitschek A; Mirzadeh S; Brechbiel MW; Colcher D
    J Nucl Med; 1989 May; 30(5):672-82. PubMed ID: 2785585
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor-associated antigen TAG-72: correlation of expression in primary and metastatic breast carcinoma lesions.
    Lottich SC; Johnston WW; Szpak CA; Delong ER; Thor A; Schlom J
    Breast Cancer Res Treat; 1985; 6(1):49-56. PubMed ID: 2996665
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Applications of monoclonal antibodies in clinical cytology as exemplified by studies with monoclonal antibody B72.3. The George N. Papanicolaou award lecture.
    Johnston WW
    Acta Cytol; 1987; 31(5):537-56. PubMed ID: 3314301
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of primary colorectal cancer with indium 111 monoclonal antibody B72.3.
    Doerr RJ; Abdel-Nabi H; Baker JM; Steinberg S
    Arch Surg; 1990 Dec; 125(12):1601-5. PubMed ID: 2244814
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Radioimmunolocalization of metastatic breast carcinoma using indium-111-methyl benzyl DTPA BrE-3 monoclonal antibody: phase I study.
    Kramer EL; DeNardo SJ; Liebes L; Kroger LA; Noz ME; Mizrachi H; Salako QA; Furmanski P; Glenn SD; DeNardo GL
    J Nucl Med; 1993 Jul; 34(7):1067-74. PubMed ID: 8315480
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.